CY1106100T1 - Υποκατεστημενες 2-(2, 6-διοξο-3-φθοροπιπepιδιν-3-υλο)-ισοϊνδολινες και η χρηση τους για μειωση των επιπεδων tnfa - Google Patents

Υποκατεστημενες 2-(2, 6-διοξο-3-φθοροπιπepιδιν-3-υλο)-ισοϊνδολινες και η χρηση τους για μειωση των επιπεδων tnfa

Info

Publication number
CY1106100T1
CY1106100T1 CY20061100821T CY061100821T CY1106100T1 CY 1106100 T1 CY1106100 T1 CY 1106100T1 CY 20061100821 T CY20061100821 T CY 20061100821T CY 061100821 T CY061100821 T CY 061100821T CY 1106100 T1 CY1106100 T1 CY 1106100T1
Authority
CY
Cyprus
Prior art keywords
dioxo
isoindolines
fluoropipepidin
substituted
tnfa levels
Prior art date
Application number
CY20061100821T
Other languages
English (en)
Inventor
George W. Muller
David I. Stirling
Roger Shen-Chu Chen
Hon-Wah Man
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/976,140 external-priority patent/US5874448A/en
Priority claimed from US09/042,274 external-priority patent/US5955476A/en
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of CY1106100T1 publication Critical patent/CY1106100T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Οι 1-οξο-2-(2,6-διοξο-3-φθοροπιπεριδιν-3-υλο)-ισοϊνδολίνες και οι 1,3-διοξο-2-(2,6-διοξο-3-φθοροπιπεριδιν-3-υλο)-ισοϊνδολίνες μειώνουν επίπεδα των φλεγμονωδών κυτοκινών όπως είναι ο TNF άλφα σε ένα θηλαστικό. Μία τυπική ενσωμάτωση είναι η 1,3-διοξο-2-(2,6-διοξο-3-φθοροπιπεριδιν-3-υλο)-ισοϊνδολίνη.
CY20061100821T 1997-11-18 2006-06-19 Υποκατεστημενες 2-(2, 6-διοξο-3-φθοροπιπepιδιν-3-υλο)-ισοϊνδολινες και η χρηση τους για μειωση των επιπεδων tnfa CY1106100T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/976,140 US5874448A (en) 1997-11-18 1997-11-18 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
US09/042,274 US5955476A (en) 1997-11-18 1998-03-13 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
EP98958016A EP1062214B1 (en) 1997-11-18 1998-11-17 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels

Publications (1)

Publication Number Publication Date
CY1106100T1 true CY1106100T1 (el) 2011-06-08

Family

ID=26719049

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100821T CY1106100T1 (el) 1997-11-18 2006-06-19 Υποκατεστημενες 2-(2, 6-διοξο-3-φθοροπιπepιδιν-3-υλο)-ισοϊνδολινες και η χρηση τους για μειωση των επιπεδων tnfa

Country Status (14)

Country Link
EP (3) EP1062214B1 (el)
AT (2) ATE233753T1 (el)
AU (1) AU752958B2 (el)
CY (1) CY1106100T1 (el)
CZ (1) CZ299808B6 (el)
DE (2) DE69834668T2 (el)
DK (1) DK1308444T3 (el)
ES (2) ES2192342T3 (el)
FI (1) FI20001192A (el)
HK (1) HK1054381B (el)
NO (1) NO318737B1 (el)
PT (1) PT1308444E (el)
SI (1) SI1308444T1 (el)
SK (1) SK7382000A3 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299253B6 (cs) * 1998-03-16 2008-05-28 Celgene Corporation Isoindolinový derivát, jeho použití pro výrobu léciva a farmaceutická kompozice tento derivát obsahující
US20050100529A1 (en) * 2003-11-06 2005-05-12 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
ES2339425T3 (es) * 1996-07-24 2010-05-20 Celgene Corporation 2-(2,6-dioxopiperidin-3-il)-ftalimidas y -1-oxoisoindolinas sustituidas y procedimiento para reducir los niveles de tnf-alfa.
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines

Also Published As

Publication number Publication date
EP1062214A1 (en) 2000-12-27
EP1308444A1 (en) 2003-05-07
DE69811962T2 (de) 2003-08-28
CZ299808B6 (cs) 2008-12-03
CZ20001822A3 (cs) 2000-11-15
AU1413899A (en) 1999-09-27
ATE327228T1 (de) 2006-06-15
PT1308444E (pt) 2006-08-31
SK7382000A3 (en) 2000-12-11
NO318737B1 (no) 2005-05-02
HK1054381A1 (en) 2003-11-28
AU752958B2 (en) 2002-10-03
ES2262753T3 (es) 2006-12-01
DK1308444T3 (da) 2006-09-18
EP1710242A1 (en) 2006-10-11
ES2192342T3 (es) 2003-10-01
SI1308444T1 (sl) 2007-04-30
FI20001192A (fi) 2000-07-14
EP1308444B1 (en) 2006-05-24
DE69811962D1 (de) 2003-04-10
DE69834668D1 (de) 2006-06-29
DE69834668T2 (de) 2007-01-11
HK1054381B (zh) 2006-10-13
ATE233753T1 (de) 2003-03-15
NO20002529D0 (no) 2000-05-16
EP1062214B1 (en) 2003-03-05
NO20002529L (no) 2000-06-30

Similar Documents

Publication Publication Date Title
TR200002627T2 (tr) İkameli 2-(2,6- (Diokso-3-floropiperidin-3-İI) -izoindolinler ve TNF alfa seviyelerini düşürmek için kullanılmaları
TR200000107T2 (tr) Sübstitüe edilmiş 2-(2,6-dioksopiperidin-3-il) -ftalimidler ve -1-oksoizoindolinler ve TNF alfa seviyelerini düşürmek için yöntem.
FI20000061A (fi) Substituoituja alkanohydroksaamihappoja ja menetelmä TNFalfa-tasojen alentamiseksi
DE69031434D1 (de) Spontane Sprach- und Datenbenachrichtigung
NO973180L (no) Sotmaterialer og polymermaterialer hvor slike inngår
NO934663L (no) Lyssender med stort sideforhold, og hoey ensartethet og direktivit et
KR900009778A (ko) 아미드 측-쇄 중합체
CY1106100T1 (el) Υποκατεστημενες 2-(2, 6-διοξο-3-φθοροπιπepιδιν-3-υλο)-ισοϊνδολινες και η χρηση τους για μειωση των επιπεδων tnfa
EA200200189A1 (ru) Применение ингибиторов интерлейкина 18
EA200200331A1 (ru) Применение лептина для ингибирования пролиферации эндотелиальных клеток
DE69738563D1 (de) Cx3c chemokin-gene von säugetieren
NO20015922L (no) Nye calpainer og anvendelse derav
KR970063266U (ko) 음성 및 멜로디가 나오는 라이타
IT234639Y1 (it) Scala portatile con un piano porta-oggetti
KR970019499U (ko) 음성 및 멜로디발생기능을 가지는 콤팩트디스크 케이스
KR920017589U (ko) 멜로디 및 cm이 울리는 쇼 케이스
KR930009145U (ko) 휴대용 조명장치
KR880004381U (ko) 보고서 및 서류 고정구
KR920013550U (ko) 키 베이스 고정장치
NO303704B1 (no) Flerledningsstreng og anvendelse derav
ITMI930809A0 (it) Dispositivo per il rilevamento della presenza di spine in prese di corrente particolarmente per utenze civili ed industriali
BR6801249U (pt) Teclado musical portatil
ITGE960010A0 (it) Utilizzo con impasti bituminosi e cementizi di ceneri tossico-nocive e ceneri normali.
IT8983490A0 (it) Dispositivo di basculamento controllato ed indipendente piano di raddrizzatura-piegatura
FI933078A (fi) Dubbeldiskraffinoer med reglerad intensitet och hoeg hastighet